Is a "Cytokine Storm" Relevant to COVID-19?

JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.

Authors

Pratik Sinha^{1

2}, Michael A Matthay^{1

2

3}, Carolyn S Calfee^{1

2

3}

Affiliations

¹ Division of Pulmonary, Department of Medicine, Critical Care, Allergy and Sleep Medicine; University of California, San Francisco.
² Department of Anesthesia; University of California, San Francisco.
³ Cardiovascular Research Institute; University of California, San Francisco.

PMID: 32602883
DOI: 10.1001/jamainternmed.2020.3313

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Betacoronavirus / physiology
COVID-19
Coronavirus Infections* / complications
Coronavirus Infections* / immunology
Coronavirus Infections* / physiopathology
Cytokine Release Syndrome* / diagnosis
Cytokine Release Syndrome* / immunology
Cytokine Release Syndrome* / therapy
Humans
Immunity, Innate / drug effects
Immunity, Innate / physiology
Immunologic Factors / immunology
Immunologic Factors / pharmacology
Interleukin-6* / analysis
Interleukin-6* / antagonists & inhibitors
Interleukin-6* / immunology
Pandemics*
Pneumonia, Viral* / complications
Pneumonia, Viral* / immunology
Pneumonia, Viral* / pathology
Pneumonia, Viral* / physiopathology
SARS-CoV-2
Terminology as Topic

Substances

Immunologic Factors
Interleukin-6

Grants and funding